Related Experiment Videos
The Brugada syndrome
P Brugada1, R Brugada, J Brugada
1Cardiovascular Center, OLV Hospital, Moorselbaan 164, 9300 Aalst, Belgium. Pedro.Brugada@pi.be
Insights
Brugada syndrome is an inherited heart condition causing sudden death, often due to SCN5A gene mutations. Early recognition of its unique ECG patterns and prompt defibrillator implantation are crucial for preventing mortality.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Brugada syndrome is a hereditary cardiac disease.
- It leads to sudden cardiac death in individuals with structurally normal hearts.
- Mutations in the SCN5A gene are the primary cause.
Purpose of the Study:
- To highlight the diagnostic electrocardiogram (ECG) features of Brugada syndrome.
- To emphasize the importance of recognizing ECG variants and concealed forms.
- To discuss the high mortality and effective treatment strategies.
Main Methods:
- Review of characteristic electrocardiogram findings in Brugada syndrome.
- Discussion of diagnostic challenges, including concealed forms.
- Analysis of treatment outcomes and mortality rates.
Main Results:
- Brugada syndrome presents with a distinct ST segment elevation in ECG leads V1-V3.
- Concealed forms require provocation with Class I antiarrhythmic drugs for diagnosis.
- Untreated patients face a significant annual mortality risk of approximately 10%.
Conclusions:
- Early recognition of Brugada syndrome's ECG patterns is vital for all physicians.
- Implantable defibrillators are the only proven effective treatment to prevent sudden death.
- Genetic testing for SCN5A mutations aids in diagnosis and family screening.
Abstract:
The Brugada syndrome is a hereditary disease causing sudden cardiac death in apparently healthy individuals with a structurally normal heart. The disease is caused by mutations in the cardiac sodium channel gene SCN5A. Patients with this disease have a peculiar electrocardiogram with elevation of the ST segment in leads V1 to V3, an electrocardiogram that every doctor should recognize. There exist variants of the electrocardiogram with minimal ST segment elevation and even concealed forms that can only be unmasked by the administration of class I antiarrhythmic drugs. When left untreated or when treated with all known antiarrhythmic drugs, patients with Brugada syndrome have a high mortality (approximately 10% per year). The only effective treatment to prevent sudden death is the implantable defibrillator.